Comparing the long‐term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease‐modifying antirheumatic drug in patients with inflammatory polyarthritis

Lignende værker

• Early treatment with, and time receiving, first disease-modifying antirheumatic drug predicts long-term function in patients with inflammatory polyarthritis
  af: Farragher, Tracey M, et al.
  Udgivet: (2009)
• Can clinical factors at presentation be used to predict outcome of treatment with methotrexate in patients with early inflammatory polyarthritis?
  af: Hider, S L, et al.
  Udgivet: (2009)
• Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis
  af: Franklin, J, et al.
  Udgivet: (2006)
• Risk and predictors of infection leading to hospitalisation in a large primary‐care‐derived cohort of patients with inflammatory polyarthritis
  af: Franklin, Jarrod, et al.
  Udgivet: (2007)
• Increasing age at symptom onset is associated with worse radiological damage at presentation in patients with early inflammatory polyarthritis
  af: Bukhari, Marwan, et al.
  Udgivet: (2007)